Blood Diseases Flashcards

1
Q

Cause: Mutations in chromosome 9 or 12, 70% of patients with arterio-venous malformations have this disorder
Presentation: cutaneous telangiectasia, epistaxis (nose bleeds), visceral involvement, GI involvement

A

Hereditary Hemorrhagic Talangiectasia (HHT-1 or HHT-2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cause: Autosomal dominant, most common hereditary bleeding disorder (7 subtypes)
Presentation: Excessive bleeding from mucosal membranes (Nose, gums, vagina), petechiae
Diagnostics: Prolonged PTT, unaffected PT

A

von Willebrand Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cause: Anti-factor VIII antibodies
Presentation: Serious or life-threatening bleeding, muscle and GI/GU bleeds are common, pregnancy/post-partum, autoimmune disease, or malignancy in older males

A

Acquired Hemophilia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cause: Mutation of thrombin binding site
Presentation: coagulation disorder, patients cannot be anti-coagulated with heparin or small molecule heparin mimics

A

Antithrombin III Deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cause: Rare autosomal recessive disorder
Presentation: Recurrent purpura fulminans in infancy, DIC, and VTE (severe), incident and recurrent VTE (mild)

A

Protein C Deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Presentation: Recurrent VTE and fetal loss (moderate), DIC and recurrent purpura fulminans in infancy (severe)

A

Protein S Deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cause: Mutation resulting in increased circulating levels of prothrombin
Presentation: Increases risk for VTE 2-3x, occurs in related populations at high risk for Factor V Leiden mutation

A

Prothrombin G2010A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cause: Autosomal dominant mutation (missense substitution) in the factor V gene, resulting in a factor V protein that resistant to activated protein C
Presentation: Increased risk for VTE

A

Factor V Leiden

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cause: Deficiency of ADAMTS13 (commonly caused by auto-antibodies)
Presentation: Thrombotic microangiopathy, related to signs and symptoms of renal and CNS microthrombi, confusion, fever, renal failure, fatal without treatment
Diagnostics: Normal PT and PTT

A

Thrombotic Thrombocytopenia Purpura (TTP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cause: Auto-antibodies that bind B2-GPI in the presence of anionic phospholipid
Presentation: Venous thromboembolism or pregnancy morbidity
Diagnostics: Lab results of anti-cardiolipin. anti-B2GPI, lupus anticoagulant activity

A

Antiphospholipid Syndrome (APLS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cause: Occurs in < 1% of APLS patients
Presentation: Thrombotic occlusions occurring in three or more organs/tissues, “thrombotic storm”, mortality approaches 50% even with optimal treatment

A

Catastrophic Antiphospholipid Syndrome (CAPS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cause: Malabsorption/dietary lack, chronic blood loss, inflammation/chronic disease
Presentation: microcytic, hypochromic cells, pica, koilonychia (spoon nails), cheilosis/glossitis/alopecia, fatigue (brain fog), possible thrombocytosis

A

Iron Deficiency Anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cause: dietary deficiency, increased requirement (pregnancy), defective absorption, metabolic disorders
Presentation: megaloblastic anemia, hyper-segmented neutrophils, “lemon-yellow” skin, atrophic glossitis (sore/smooth tongue)

A

Folate Deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cause: Decreased intake, increased requirement, defective absorption
Presentation: megaloblastic anemia, peripheral neuropathy, dorsal and lateral tract symptoms, dementia

A

Vitamin B-12 Deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cause: Immune or viral (Parvovirus B19) attack on erythrocyte progenitors, auto-immune in association with driving malignancy
Presentation: anemia, aplastic crisis in patients with prior anemia, severely low reticulocyte count

A

Pure Red Cell Aplasia (Aplastic Crisis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cause: Immune or viral (CMV/EBV) attack on progenitor cells, direct toxic damage, inherited marrow defect
Presentation: anemia, increased fat storage in bone marrow, short stature, musculoskeletal abnormalities, dysplastic nails, skin changes

A

Aplastic Anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cause: autosomal dominant (or recessive) hemolytic anemia disorder (most common in Northern European people but can affect any ethnic group), AD: B-spectrin unable to bind to ankyrin, AR: a-spectrin unable to bind to ankyrin, leads to inability of cytoskeleton to bind to cell membrane, spherocytes become trapped in spleen

Presentation: well-compensated hemolysis with periodic exacerbations (fatigue, jaundice, splenomegaly), normocytic/normochromic
Diagnosis: Osmotic fragility test, Band 3 Erythrocyte Membrane Assay

A

Hereditary Spherocytosis (HS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cause: defect in a-spectrin, b-spectrin and band 4.1 genes causing horizontal defect
Presentation: homozygotes have chronic hemolysis, worse with stress

A

Hereditary Elliptocytosis

19
Q

Cause: acquired genetic defect in PIGA gene in hematopoietic cell leading to loss of anchor proteins, lack of CD55/CD59 results in RBC destruction by complement
Presentation: hemolysis and atypical thrombosis due to inflammation, aplastic anemia, fatigue, chest pain, headaches, impotence

A

Paroxysmal Nocturnal Hemoglobinuria (PNH)

20
Q

Cause: X-linked disorder, most common enzyme disorder, enzyme unable to reduce in settings of oxidative stress
Presentation: hemolysis associated with certain drugs, lab findings of poikilocytes, blister cells, bite cells, spherocytes, Heinz Bodies

A

G6PD Deficiency

21
Q

Cause: autosomal recessive
Presentation: RBCs become rigid due to decreased ATP, mild to severe hemolytic anemia, jaundice, gallstones

A

Pyruvate Kinase Deficiency

22
Q

Cause: IgG antibodies directed non-specifically at Rh complex, RBCs coated in IgG and complement and destroyed by macrophages
Presentation: Pallor, fatigue, splenomegaly, elevated LDH, Coombs test positive, microspherocytes

A

Warm Antibody Auto-Immune Hemolytic Anemia (AIHA)

23
Q

Cause: IgM antibodies after infection bind RBCs and activate complement, intravascular and extravascular hemolysis
Presentation: Usually self-limited hemolytic anemia

A

Cold Auto-Immune Hemolytic Anemia (AIHA)

24
Q

Cause: IgG directed at the P blood group antigens after viral infection or syphilis, caused by Donath-Landsteiner antibody
Presentation: Dark urine

A

Paroxysmal Cold Hemoglobinuria (Rare type of Cold AIHA)

25
Q

Cause: immune complexes, hapten formation, autoantibody induction, nonspecific adsorption of Igs
Presentation: Hemolytic anemia

A

Drug-Induced Immunohemolytic Anemia

26
Q

Cause: Sickle Cell Disease (main cause of death for HbSS patients)
Presentation: Pulmonary vaso-occlusive crisis, chest pain, progressive pulmonary infiltrates, progressive/refactory arterial hypoxemia

A

Acute Chest Syndrome

27
Q

Cause: obstruction of splenic veins
Presentation: hypotension, tachycardia, massive splenomegaly, pancytopenia, risk of sepsis, organ damage results in “autosplenectomy”

A

Splenic Sequestration Crisis

28
Q

Cause: venous occlusion of corpora cavernosa
Presentation: Intermittent or persistent painful erections

A

Priapism

29
Q

Cause: “Loop-deletion” of alpha globin genetics (prevalent in Asia and Africa)
Presentation: mild to severe anemia, target cells, microcytosis, MI < 12

A

Alpha Thalassemia

30
Q

Cause: Homozygous mutations in Beta globin genes (B0/B0, B+/B0)
Presentation: Severe anemia, microcytosis, reticulocytosis, frontal bossing/splayed teeth, hepatosplenomegaly

A

Beta Thalassemia

31
Q

Cause: Sporadic > AD > AR
Presentation: Recurrent infections, ANC < 200/ul

A

Severe Congenital Neutropenia

32
Q

Cause: AD > Sporadic
Presentation: recurrent infections AND mouth sores, ANC 200-500 /ul, 14-21 day cycle

A

Cyclic Neutropenia

33
Q

Cause: Analgesics, anti-thyroid drugs, antibiotics, antipsychotics, Phenothiazines
Presentation: Decreased ANC

A

Drug-Induced Neutropenia

34
Q

Cause: RA, SLE, Sjogrens syndrome
Presentation: decreased ANC

A

Autoimmune neutropenia

35
Q

Cause: FAS mediated apoptosis
Presentation: neutropenia, anemia, thrombocytopenia

A

LGL leukemia

36
Q

Cause: Autosomal recessive abnormal expression or activity of GP-Ib complex
Presentation: Platelet type bleeding, mild thrombocytopenia, giant platelets

A

Bernard-Soulier Syndrome

37
Q

Cause: AR GPIIb or GP IIIa defect
Presentation: platelet defect disorder

A

Glamzmann Thrombasthenia

38
Q

Cause: Auto-antibodies against GP IIb/IIIa, low levels of TPO
Presentation: peripheral thrombocytopenia, normal or increased megakaryocytes in bone marrow, absence of splenomegaly, children <20K platelets, bleeding in adults <50K

A

Idiopathic Thrombocytopenic Purpura (ITP)

39
Q

Cause: drugs, connective tissue diseases, lymphoproliferative disease, infections (CMV, HIV, EBV, Hep B/C, V. Zoster, H. Pylori), HIT/HITT
Presentation: Decreased platelet count

A

Secondary Autoimmune Thrombocytopenia

40
Q

Cause: Shiga toxin in children
Presentation: Renal failure, diarhea

A

Hemolytic Uremic Syndrome (HUS)

41
Q

Cause: Sepsis, malignancy, amniotic fluid embolism, snake bites
Presentation: Thrombocytopenia, intravascular consumption of platelets, thrombosis, bleeding

A

Disseminated Intravascular Coagulation (DIC)

42
Q

Cause: Known genetic defect, disregulation in NK, CD8, and T-cell function
Presentation: Fever, splenomegaly, cytopenia, hypertriglyceridemia, hyperfibrinogenemia, decreased or absent NK activity

A

Hemophagocytic Lymphohistiocytosis (HLH)

43
Q

Mutations in regulators of complement activation and inhibition leading to unchecked activated complement pathway

A

Atypical Hemolytic Uremic Syndrome (aHUS)